Avestar Capital, LLC Illumina, Inc. Transaction History

Avestar Capital, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$127.73 - $147.2 $210,115 - $242,143	1,645 New	1,645 $225,000
Q2 2022 Jul 28, 2022	SELL	$181.58 - $368.0 $154,343 - $312,800	-850 Closed	0 $0
Q1 2022 Apr 26, 2022	BUY	$303.87 - $423.8 $35,856 - $50,008	118 Added 16.12%	850 $297,000
Q4 2021 Feb 01, 2022	SELL	$347.28 - $421.83 $21,531 - $26,153	-62 Reduced 7.81%	732 $278,000
Q3 2021 Nov 09, 2021	BUY	$405.61 - $524.84 $44,617 - $57,732	110 Added 16.08%	794 $322,000
Q2 2021 Aug 03, 2021	BUY	$372.84 - $481.5 $21,624 - $27,927	58 Added 9.27%	684 $324,000
Q1 2021 May 03, 2021	SELL	$361.28 - $504.76 $75,868 - $105,999	-210 Reduced 25.12%	626 $254,000
Q4 2020 Feb 01, 2021	BUY	$292.7 - $370.96 $244,697 - $310,122	836 New	836 $309,000
Q3 2019 Nov 14, 2019	SELL	$266.84 - $378.23 $4,803 - $6,808	-18 Closed	0 $0
Q4 2018 Jan 25, 2019	BUY	$272.46 - $366.54 $817 - $1,099	3 Added 20.0%	18 $3,000
Q2 2018 Aug 10, 2018	BUY	$228.17 - $292.07 $1,825 - $2,336	8 Added 114.29%	15 $2,000
Q1 2018 May 10, 2018	BUY	$209.54 - $253.91 $628 - $761	3 Added 75.0%	7 $1,000
Q4 2017 Feb 14, 2018	BUY	$202.23 - $230.03 $808 - $920	4	4 $0

908

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $21.4B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Avestar Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Avestar Capital, LLC with notifications on news.